Met Life Investment Management, LLC Editas Medicine, Inc. Transaction History

Met Life Investment Management, LLC

  • $17.1 Billion
  • Q3 2024

A detailed history of Met Life Investment Management, LLC transactions in Editas Medicine, Inc. stock. As of the latest transaction made, Met Life Investment Management, LLC holds 29,518 shares of EDIT stock, worth $38,668. This represents 0.0% of its overall portfolio holdings.

Number of Shares
29,518
Previous 47,255 37.53%
Holding current value
$38,668
Previous $220,000 54.55%
% of portfolio
0.0%
Previous 0.0%

Shares

46 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
SELL
$3.39 - $5.96 $60,128 - $105,712
-17,737 Reduced 37.53%
29,518 $100,000
Q2 2024

Aug 13, 2024
BUY
$4.67 - $7.28 $40,624 - $63,328
8,699 Added 22.56%
47,255 $220,000
Q1 2024

May 14, 2024
BUY
$7.03 - $11.07 $271,048 - $426,814
38,556 New
38,556 $286,000
Q3 2023

May 09, 2024
BUY
$6.92 - $9.31 $44,585 - $59,984
6,443 Added 17.34%
43,591 $340,000
Q3 2023

Apr 29, 2024
BUY
$6.92 - $9.31 $44,585 - $59,984
6,443 Added 17.34%
43,591 $340,000
Q3 2023

Nov 14, 2023
BUY
$6.92 - $9.31 $44,585 - $59,984
6,443 Added 17.34%
43,591 $340,000
Q2 2023

Apr 29, 2024
BUY
$6.36 - $11.47 $236,261 - $426,087
37,148 New
37,148 $305,000
Q1 2023

May 09, 2024
BUY
$7.03 - $11.53 $261,150 - $428,316
37,148 New
37,148 $269 Million
Q1 2022

May 10, 2024
BUY
$14.08 - $27.63 $523,043 - $1.03 Million
37,148 New
37,148 $706,000
Q1 2022

Mar 22, 2023
BUY
$14.08 - $27.63 $190,727 - $374,275
13,546 Added 57.39%
37,148 $706,000
Q1 2022

May 12, 2022
BUY
$14.08 - $27.63 $190,727 - $374,275
13,546 Added 57.39%
37,148 $707,000
Q4 2021

Jun 21, 2023
SELL
$26.55 - $40.57 $359,646 - $549,561
-13,546 Reduced 36.46%
23,602 $626,000
Q3 2021

May 17, 2024
SELL
$39.27 - $72.94 $52,857 - $98,177
-1,346 Reduced 5.4%
23,602 $969,000
Q3 2021

Jun 21, 2023
SELL
$39.27 - $72.94 $531,951 - $988,045
-13,546 Reduced 36.46%
23,602 $969,000
Q3 2021

Mar 22, 2023
SELL
$39.27 - $72.94 $52,857 - $98,177
-1,346 Reduced 5.4%
23,602 $969,000
Q3 2021

Nov 15, 2021
SELL
$39.27 - $72.94 $52,857 - $98,177
-1,346 Reduced 5.4%
23,602 $970,000
Q2 2021

Jun 21, 2023
SELL
$31.29 - $56.64 $381,738 - $691,008
-12,200 Reduced 32.84%
24,948 $1.41 Million
Q1 2021

May 17, 2024
SELL
$39.71 - $90.58 $540,373 - $1.23 Million
-13,608 Reduced 35.29%
24,948 $1.05 Million
Q1 2021

Jun 26, 2023
SELL
$39.71 - $90.58 $484,462 - $1.11 Million
-12,200 Reduced 32.84%
24,948 $1.05 Billion
Q4 2020

May 24, 2024
SELL
$27.07 - $84.35 $46,587 - $145,166
-1,721 Reduced 6.45%
24,948 $1.75 Million
Q4 2020

Jun 22, 2023
SELL
$27.07 - $84.35 $330,254 - $1.03 Million
-12,200 Reduced 32.84%
24,948 $1.75 Million
Q4 2020

Mar 22, 2023
SELL
$27.07 - $84.35 $46,587 - $145,166
-1,721 Reduced 6.45%
24,948 $1.75 Million
Q4 2020

Feb 16, 2021
SELL
$27.07 - $84.35 $46,587 - $145,166
-1,721 Reduced 6.45%
24,948 $1.75 Million
Q3 2020

May 24, 2024
BUY
$28.06 - $37.16 $53,791 - $71,235
1,917 Added 7.74%
26,669 $748 Million
Q3 2020

Jun 26, 2023
SELL
$28.06 - $37.16 $294,040 - $389,399
-10,479 Reduced 28.21%
26,669 $748,000
Q3 2020

Mar 22, 2023
BUY
$28.06 - $37.16 $53,791 - $71,235
1,917 Added 7.74%
26,669 $748,000
Q3 2020

Nov 13, 2020
BUY
$28.06 - $37.16 $53,791 - $71,235
1,917 Added 7.74%
26,669 $748,000
Q2 2020

May 24, 2024
SELL
$18.5 - $34.34 $255,374 - $474,029
-13,804 Reduced 35.8%
24,752 $732 Million
Q2 2020

Jun 26, 2023
SELL
$18.5 - $34.34 $229,326 - $425,678
-12,396 Reduced 33.37%
24,752 $732,000
Q2 2020

Mar 22, 2023
BUY
$18.5 - $34.34 $59,829 - $111,055
3,234 Added 15.03%
24,752 $732,000
Q2 2020

Aug 14, 2020
BUY
$18.5 - $34.34 $59,829 - $111,055
3,234 Added 15.03%
24,752 $732,000
Q1 2020

Jul 12, 2023
SELL
$14.88 - $32.78 $232,574 - $512,351
-15,630 Reduced 42.07%
21,518 $426,000
Q4 2019

Jul 12, 2023
SELL
$19.49 - $32.63 $304,628 - $510,006
-15,630 Reduced 42.07%
21,518 $637,000
Q3 2019

Jul 12, 2023
SELL
$22.49 - $26.81 $351,518 - $419,040
-15,630 Reduced 42.07%
21,518 $489,000
Q3 2019

Mar 22, 2023
BUY
$22.49 - $26.81 $7,961 - $9,490
354 Added 1.67%
21,518 $489,000
Q3 2019

Nov 14, 2019
BUY
$22.49 - $26.81 $7,961 - $9,490
354 Added 1.67%
21,518 $489,000
Q2 2019

Jul 12, 2023
SELL
$20.48 - $27.76 $243,630 - $330,232
-11,896 Reduced 32.02%
25,252 $624,000
Q1 2019

Jul 13, 2023
SELL
$19.43 - $26.41 $310,569 - $422,137
-15,984 Reduced 43.03%
21,164 $517,000
Q4 2018

Jul 13, 2023
SELL
$18.19 - $31.79 $290,748 - $508,131
-15,984 Reduced 43.03%
21,164 $481,000
Q4 2018

Mar 22, 2023
SELL
$18.19 - $31.79 $212,331 - $371,084
-11,673 Reduced 35.55%
21,164 $481,000
Q4 2018

Feb 14, 2019
SELL
$18.19 - $31.79 $212,331 - $371,084
-11,673 Reduced 35.55%
21,164 $481,000
Q3 2018

Jul 13, 2023
SELL
$27.65 - $38.39 $441,957 - $613,625
-15,984 Reduced 43.03%
21,164 $673,000
Q3 2018

Mar 22, 2023
SELL
$27.65 - $38.39 $119,199 - $165,499
-4,311 Reduced 11.6%
32,837 $1.04 Million
Q3 2018

Nov 14, 2018
BUY
$27.65 - $38.39 $322,758 - $448,126
11,673 Added 55.15%
32,837 $1.05 Million
Q2 2018

Aug 15, 2018
BUY
$31.4 - $41.01 $144,785 - $189,097
4,611 Added 27.86%
21,164 $758,000
Q4 2017

Feb 15, 2018
BUY
$21.89 - $31.34 $362,345 - $518,771
16,553
16,553 $509,000

Others Institutions Holding EDIT

# of Institutions
248
Shares Held
57M
Call Options Held
410K
Put Options Held
394K
View Full List

About Editas Medicine, Inc.

EDIT Quotes by TradingView
  • Ticker EDIT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 68,737,200
  • Market Cap $90M
  • Description
  • Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...
More about EDIT
Track This Portfolio

Track Met Life Investment Management, LLC Portfolio

Follow Met Life Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email